SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

The market is focused on the expected interest rate decision, with community chatter split between anticipating a rally or a "sell the news" reaction. Many traders believe a 0.25% rate cut is already priced in, while others are closely watching Fed Chair Powell's commentary for further cues on the economic outlook and future monetary policy. Community members also discuss potential sector rotations and the impact of rate decisions on various asset classes.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as the market anticipates the Fed's rate decision, with widespread expectation of a 25 bps cut. Community members are closely watching Powell's tone and forward guidance, as well as potential sector rotations and the impact on small caps. Uncertainty surrounding inflation and labor market conditions adds to the speculation around the technology-heavy index.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor (OPEN) is trending amid discussions about the Federal Reserve's rate cut decision and its potential impact on the housing market; the community is debating whether the rate cut will stimulate growth or if it was already priced in. Some traders are pointing to the company's expansion plans as a catalyst, while others speculate about potential announcements from the CEO. Overall, the conversation revolves around the tug-of-war between bullish hopes for real estate and bearish concerns about market reactions.

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is trending as traders anticipate potential impacts from upcoming Fed guidance on interest rates, with some expecting a significant move. Community members are also actively discussing new Solana token mints and memecoin opportunities associated with Bitcoin. Many are positioning themselves for a potential breakout, while others remain cautious, anticipating a possible "sell the news" event following any announcement.

BlackRock Institutional Trust Company N.A. - iShares Russell 2000 ETF

iShares Russell 2000 ETF

IWM is trending due to anticipation surrounding a potential Federal Reserve rate cut, with the market pricing in possible easing. Community discussions revolve around the impact of rate cuts on small-cap stocks and whether the expected news is already priced in, potentially leading to a "sell the news" event. Traders are closely watching for signals about the Fed's future policy and its effects on various sectors, especially small caps.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai ($BBAI) is trending due to a combination of factors, including increased institutional buying from Goldman Sachs and a congresswoman's disclosed investment. The community is actively discussing the potential for a short squeeze and the impact of upcoming Fed decisions on the stock's momentum, as well as potential government contracts. Overall sentiment appears bullish, with many anticipating further gains and a breakout above key resistance levels.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as traders anticipate potential Fed rate cuts following recent economic data and await upcoming CPI and PPI reports, leading to discussions about recession risks and the bond market's next move. Community perspectives range from expectations of a bond rally to concerns about stagflation, with some highlighting the influence of tariffs and potential central bank actions. The conversation also involves analysis of technical indicators and potential trading strategies.

SSgA Active Trust - SPDR Dow Jones Industrial Average ETF

DIA is trending due to speculation around potential Fed rate cuts following weaker-than-expected jobs data, with the community debating whether this is a bull trap or a genuine signal for further market gains. Community members are closely watching upcoming inflation reports for further clues, while some express concern about the reliability of economic data. Debate continues about whether to "buy the dip" or prepare for a significant correction.

TOSHI

TOSHI.X is trending amid community excitement around new exchange listings, particularly in South Korea, and speculation about potential future listings on major platforms like Binance. Talk of a recent partnership with Coinbase is circulating, as well as anticipation surrounding potential interest rate cuts and their impact on the crypto market. The community is also actively discussing the coin's technical outlook and potential for significant gains.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Conversations around Webull Corp (BULL) are focused on potential dilution and reverse splits, with some traders expressing frustration over the stock's performance despite broader market gains and upcoming rate cut decisions. Community sentiment is mixed, with some calling it a "garbage" stock and others anticipating a potential short squeeze or a move to higher price targets, especially with the potential of rate cuts. Some are drawing comparisons to similar companies, mentioning potential catalysts to be a breakout stock like competitors $HOOD and $SOFI.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Adverum Biotechnologies (ADVM) Receives a Buy from Oppenheimer

In a report released today, Francois Brisebois from Oppenheimer maintained a Buy rating on Adverum Biotechnologies (ADVM Research Report), with a...

Buy Rating for Adverum Biotechnologies Based on Promising Ixo-Vec Therapy and Strategic Growth Opportunities

TD Cowen analyst Joseph Thome has maintained their bullish stance on ADVM stock, giving a Buy rating on August 2. Joseph Thome has given his Buy ra...

Adverum Releases Interim Data From Gene Therapy Study For Blindness Disorder, Prepares For Pivotal Study

Adverum Biotechnologies presented 26-week interim data from the LUNA Phase 2 trial for Ixo-vec in wet AMD. The analysis showed significant reductions in anti-VEGF injections and positive visual...

Shares of 4D Molecular Therapeutics Inc. (FDMT) plummeted over 35% to $17.30 by Wednesday afternoon, marking it as the top loser among U.S. stocks. Surprisingly, retail traders remain highly bullish on the stock, with Stocktwits sentiment extremely bullish (85/100) amid extremely high message volumes (95/100).<figure class="image"><img style="aspect-ratio:1308/308;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/FDMT_Sentiment_Meter_On_Jul_17_5f2f85024d.png" alt="FDMT Stocktwits Sentiment Meter On Jul 17" width="1308" height="308"><figcaption>FDMT Stocktwits Sentiment Meter On Jul 17</figcaption></figure>Initially, FDMT shares climbed following the release of encouraging mid-stage clinical study results for its 4D-150 gene therapy, aimed at treating wet age-related macular degeneration (wAMD), a chronic eye disorder that leads to blurred vision or blind spots in central vision.However, the broader market turned its focus to various downside risks, including safety concerns raised by RBC Capital. While the firm maintains 4D-150 is "best in class," it flagged a "safety blip" – one case of inflammation in a patient with a history of syphilis, Investing.com <a href="https://in.investing.com/news/stock-market-news/4d-molecular-therapeutics-tumbles-following-midstage-clinical-study-results-432SI-4316187">reported</a>. BMO Capital lowering the price target further may have added to the pressure.Despite the sell-off, retail investors on Stocktwits seem to view Wednesday’s crash as a buying opportunity. One user noted that 4D’s peers, Ocular Therapeutix Inc. (OCUL), Adverum Biotechnologies Inc (ADVM) and EyePoint Pharmaceuticals Inc. (EYPT), “are taking it on the chin today.”“Obviously, Nasdaq taking it hard today as well. &nbsp;Perhaps, just a general opinion of overvaluation and market fatigue? &nbsp;Very odd stock movement to me, I do expect it will reverse soon,” said Stocktwits user ‘<a href="https://stocktwits.com/ehschunk/message/579821570">ehschunk</a>’.<figure class="image"><img style="aspect-ratio:1318/454;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/FDMT_stocktwits_comment_Jul_17_88b7f49b68.png" alt="Stocktwits user ehschunk's post on FDMT stream" width="1318" height="454"><figcaption>Stocktwits user ehschunk's post on FDMT stream</figcaption></figure>The overall market sentiment didn’t help, as U.S. stocks pulled back from their all-time highs on Wednesday, impacted by falling chip and tech stocks, though the Dow Jones managed its sixth consecutive day of gains.FDMT shares are down over 19% year-to-date, contrasting with OCUL’s impressive 65% rise. EYPT has had an even tougher year, losing 57% so far, while ADVM has lost only 0.18%.However, FDMT’s consistent performance in beating EPS estimates for the past four quarters provides some relief and hope for a rebound among its retail investors.

Wall Street’s Top Loser Today Stays In Retail’s Good Books: Stocktwits Extremely Bullish On FDMT

Despite a 35% drop in shares, retail investors remain bullish on 4D Molecular Therapeutics

Wall Street’s Top Loser Today Remains In Retail’s Good Books

Equity

Despite a 35% drop in shares, retail investors remain bullish on 4D Molecular Therapeutics on promising clinical study results

Adverum Biotechnologies (ADVM, $13.89) Aroon Indicator entered a Downtrend on April 01, 2024.

For the last three days, A.I.dvisor has detected that ADVM's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Short Interest Update

Adverum Biotechnologies, Inc. (NASDAQ:ADVM  Get Free Report) saw a significant decline in short interest in March. As of March 15th, there was short interest totalling 648,500 shares, a...

Adverum Biotechnologies (ADVM, $14.09) Aroon Indicator entered a Downtrend on March 28, 2024.

Adverum Biotechnologies (ADVM, $14.67) Aroon Indicator entered a Downtrend on March 27, 2024.

Adverum Biotechnologies (ADVM, $14.14) Aroon Indicator entered a Downtrend on March 26, 2024.

Adverum Biotechnologies (NASDAQ:ADVM) Upgraded to Hold at StockNews.com

Adverum Biotechnologies (NASDAQ:ADVM  Get Free Report) was upgraded by research analysts at StockNews.com from a sell rating to a hold rating in a research note...

Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA.

Adverum Biotechnologies Inc

Just the one

Three

Four

The Fed just cut rates. How many cuts do you expect in all of 2025? 
 
*Powered by Polymarket

ADVM
Adverum Biotechnologies Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ADVM News

ADVM Adverum Biotechnologies Inc